| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6061207 | Sleep Medicine | 2012 | 9 Pages |
Abstract
Our analyses suggest that the risk for clinically relevant augmentation for the duration of up to 18Â months of rotigotine treatment is low.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Heike BeneÅ¡, Diego GarcÃa-Borreguero, Luigi Ferini-Strambi, Erwin Schollmayer, Andreas Fichtner, Ralf Kohnen,